Zinzino announced its preliminary sales results for 2025. Group revenue increased 46% in the fourth quarter, reaching $113 million, and contributing to a full year 2025 revenue increase of 51%, when compared to 2024.

Innovation has been the heartbeat of direct selling for more than 150 years. It is what transformed a door-to-door book business into a $200 billion global industry that now spans wellness, beauty, home, energy, real estate, financial services and travel. And it is what must carry us forward again.

Across the channel, companies that introduce equity initiatives consistently report the same benefits: a more inclusive culture, a deeper sense of contribution, improved field performance, higher retention through vesting, greater continuity of tribal knowledge and a powerful alignment between personal effort and enterprise value.

Zinzino reported its preliminary sales results for November 2025. Zinzino group revenue grew 45% overall year-over-year. Zinzino sales markets grew 49% year-over-year, reaching $39 million, while Faun Pharma’s external sales experienced decline. Accumulated revenue from January 2025 to November 2025 increased by 54% year-over-year to $320 million. The Asia-Pacific market, which includes Australia, New Zealand, […]

Direct Selling News is excited to unveil its preliminary list of direct selling product companies who have experienced at least 20% year-over-year growth, demonstrating true momentum either domestically or globally.

Zinzino announced its interim report for the third quarter of 2025. Revenue during the quarter was $82 million, representing 47% growth when compared to the same quarter last year. Gross profit was $29 million with a gross profit margin of 35.4%. EBITDA during the quarter was $11.5 million with an EBITDA margin of 14%. The company’s acquisition of Zurvita and stronger gross profit has supported improvements in its EBITDA margin. Net profit was $9.4 million with cash flow from operating activities of $14.3 million. During the quarter, the health segment made up 93% of total sales.

Zinzino AB announced it has acquired 35% of shares in Xion International Group. The strategic acquisition is part of Zinzino’s broader goal of further developing its own production of omega-3 oil and spirulina.

Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company's distributor database and associated customer register, inventory, and IP rights.

Zinzino reported its preliminary October 2025 revenue. Compared to October 2024, overall revenue for the company increased 65%, totaling $34 million. Accumulated revenue for year-to-date 2025 improved 55% to $274 million.

Zinzino celebrated its 20th anniversary with approximately 5,000 leaders at its Vision 2025 Annual Event in Oslo, Norway. The milestone celebration combined inspiration, recognition and scientific breakthrough reveals that the company believes will define its next era.

Zinzino announced its new Gut Health Test, a commercial test that can be conducted at home with a finger prick. The analysis measures gut bacteria production and how the body responds, offering insight into how a person’s diet and lifestyle affect immune defense and overall health. This finger prick system replaces the traditional stool sample […]

The past two years have been a season of resets. Bankruptcies, closures and pivots captured the headlines, but another equally important story has been consolidation. While the word can feel like a euphemism for weakness, the reality is more nuanced.